53
Criminal Justice and Substance Abuse Treatment David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Embed Size (px)

Citation preview

Page 1: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Criminal Justice and Substance Abuse Treatment

David FarabeeIntegrated Substance Abuse ProgramsUCLA Department of Psychiatry & Biobehavioral Sciences

Page 2: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Disclosure InformationCriminal Justice & Substance Abuse TreatmentDavid Farabee, PhD

Continuing Medical Education committee members and those involved in the planning of this CME Event have no financial relationships to disclose.

David Farabee, PhD

I have no financial relationships to disclose-and

I will not discuss off label use and/or investigational use in my presentation

Page 3: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Prevalence of Drug Use Among Offenders

Page 4: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Past-Month Drug Use among Probationers and Non-Probationers

Illicit Drug Use (Past Mo)

Illicit Drug Dependence

(Past Yr)

Alcohol Abuse/Dep

(Past Yr)

AOD Dep/Abuse (Past Yr)

0

5

10

15

20

25

30

35

40

45

31.1

18.4

33.8

41.7

13.5

4.6

13.615.9

Probationers General Population(SAMHSA, 2009)

Page 5: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

ADAM (UA) Results Use of any drug among arrestees in

2010 ranged from 52% in Washington, D.C. to 83% in Chicago.

Marijuana was most common; Cocaine is on the decline.

Opiates showed the greatest increases over the past 5 years: Portland: 10% to 22% Sacramento: 6% to 11% Indianapolis: 5% to 11%

Page 6: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Routes of Influence

Economic-CompulsiveIntentional crime that results from drug users engaging in an economically oriented crime to support their own addiction.

Pharmacological Crimes that occur as a result of

the excitability, paranoia, or poor impulse control associated with use of certain drugs.

SystemicCrimes associated with drug manufacturing and distribution.

(Goldstein (1985). JDI, 15, 493-506 )

Page 7: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Violence: The Big Picture

Most alcohol and drug use occurs among persons who are not violent.

Individual histories of aggression and violence are key to predicting whether drug use will increase these behaviors.

Alcohol is more closely related to murder, rape, and assault than any other substance (Parker & Rebhun, 1995).

For a review, see Boles & Miotto (2003). Aggression & Violent Behavior, 8, 155-174. For a review, see Boles & Miotto (2003). Aggression & Violent Behavior, 8, 155-174.

Page 8: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Public Health and Safety Consequences

IDU accounts for 7% of new HIV cases among males; 14% of cases among females (CDC, 2009);

Prevalence of HCV among IDUs is 35% (Amon et al.,

2008); Over the course of an addiction career, periods of

elevated narcotics use are associated with commensurate increases in both property crime and drug dealing (Anglin & Speckart, 1988);

The risk of death among parolees 2 weeks following release is ~ 13 times > than that of the general population, with drug overdose being the leading cause (Binswanger et al., 2007).

Page 9: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Assessing Drug Use and Treatment Needs Among Offenders

Page 10: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Stages of Risk Assessment

Professional judgment Evidence-based tools Evidence-based and dynamic Systematic and comprehensive

Andrews et al. (2006) Crime & Delinquency, 52, 7-27.

Page 11: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Value of Actuarial Approaches

Clinical Versus Statistical Prediction: A Theoretical Analysis and a Review of the Evidence (Meehl, 1954/1996);

20 published studies comparing the predictive efficacy of informal clinical judgments with that of standardized assessments;

In every one of these comparisons, the actuarial approaches performed as well as or better than the subjective approaches.

Page 12: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Two Studies

Validate COMPAS Needs Scales Concurrent validity (with relevant LSI-R

scales) Validate Treatment Effectiveness

Assessment (TEA) Compare with ASI Examine concordance with UA results

Page 13: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Overlapping Constructs of the COMPAS and LSI-R Assessments

COMPAS LSI-RCriminal Involvement Criminal HistoryHistory of Non Compliance History of Violence Current Violence Criminal Associates/Peers CompanionsSubstance Abuse Alcohol/Drug ProblemsFinancial Problems/Poverty FinancialVocational/Education Problems Education/EmploymentCriminal Thinking Attitudes/OrientationFamily Criminality Family/MaritalSocial Environment Problems Leisure and Recreation Leisure/RecreationResidential Instability AccommodationSocial Adjustment Problems Socialization Failure Criminal Opportunity Criminal Personality Social Isolation

Page 14: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Four Yes/No Questions:

Do you need substance abuse treatment?

Do you need help earning a high school diploma/GED?

Do you need help learning skills that will help you find employment?

Do you need help finding a safe place to live?

Page 15: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

% of “High-Need” Inmates Identified Using Single Item (N=75)

Substance Abuse

Financial Housing Educ/Voc0

10

20

30

40

50

60

70

80

90

100

COMPASLSI-R

Page 16: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Correlations with TABE Reading Score

COMPAS LSI-R Single Item TABE

COMPAS 1.0 .41*** .23* -.31**

LSI-R 1.0 .40*** -.16

Single Item 1.0 -.34**

TABE 1.0

Page 17: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

TEA vs ASI

Treatment Effectiveness Assessment (Ling et al., 2013) Please rate your drug use on a 0-10

scale (0=problematic - 10=doing well) Addiction Severity Index

13 questions combined using a weighting scheme, computer scored.

R=-.34 (p <.001; N=300)

Page 18: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Comparisons of TEA/ASI Scores by UA Result (N=300)

UA - UA+ Sig.

ASI .17 (SD=.10)

.23 (SD=.10)

P <.001

TEA 4.6 (SD=2.9)

3.4 (SD=2.2)

P <.001

Page 19: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

6-Mo. RTC by Motivation for and Receipt of Treatment (N=800)

Treated Untreated0

5

10

15

20

25

30

35

4038

21

2731

No Desire for TreatmentDesire for Treatment%

RTC

Page 20: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Interventions for AOD-Involved Offenders

Page 21: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Drug Courts

Testing and Sanctions

Pharmacotherapies

Page 22: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Drug Courts

Page 23: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Overview of Drug Courts

First established in Florida in 1989 Nearly 1,700 drug courts currently

exist in the U.S. Emphasis on treatment, regular

court hearings, frequent testing, and graduated sanctions

Page 24: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Baltimore City Drug Court—A Randomized Comparison (3 Yrs)

% Rearrested % Reconvicted0

102030405060708090

100 78

58

88

64

Treatment (n=139) Control (n=96)

Gottfredson et al. (2006)

Page 25: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

GAO Review (2005)

117 drug court evaluations between May 1997 and January 2004 27 were selected

Must have comparison group Must have recidivism, drug use, or

completion outcome 8 of the studies provided cost-benefit

data

Page 26: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

GAO Findings

Typical program lasts about 1 year Completion rates range from 27% to 66% Drug court participants were less

criminally active than non-participants (both during and after treatment)

Drug test results showed lower use among drug court participants while in treatment, self reported levels did not differ

Cost savings ranged from $1,000-$15,000 per participant

Page 27: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

“[W]e were unable to find conclusive evidence that the specific drug court components, such as the behavior of the judge, treatment provided, level of supervision, and sanctions for noncompliance affect the participants’

[outcomes]” (GAO, 2005; p.6)

Page 28: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Testing & Sanctions

Page 29: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Testing & Sanctions

Regular, random drug testing Swift and certain consequences for

positive tests No a priori assumption of the need

for treatment

Page 30: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Superior Court Drug Intervention Program—Design

Random assignment to— Sanctions docket [graduated

sanctions, random testing, judicial monitoring]

Treatment docket [weekly drug testing and intensive day treatment]

Standard docket [weekly drug testing, monitoring, and encouragement to enter treatment]

Page 31: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Superior Court Drug Intervention Program—Results

Sanctions Treatment Standard0

5

10

15

20

25

30

19

26 2727

22

11ArrestsAll clean UAs

%

Harrell et al., 2000

Page 32: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

The HOPE Program

Warning hearings H.O.P.E. hotline > 1 weekly random drug testing (6x per

mo) Every violation (e.g., dirty UA or missed

appointment) leads to an immediate arrest and sanction

Short terms, typically 2 days (served on weekend if employed). Terms increase for repeat violations.

Page 33: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

RCT Outcomes

Outcome HOPE Control

No-shows for probation appointments

(average of appointments per

probationer)

9% 23%

Positive urine tests (average of tests

per probationer)

13% 46%

New arrest rate (probationers

rearrested)

21% 47%

Revocation rate (probationers

revoked)

7%* 15%

Incarceration (days sentenced) 138 days* 267 days

Page 34: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Treatment Provider Perceptions of Why Prop 36 Cients Did Not Complete Treatment

63%

74%

18%

30%

17%19%

0

10

20

30

40

50

60

70

80

Transportation Work schedule Housing Familyresponsibilities

Unwilling tocomply

Motivation

Perc

en

t

Notes: Data are from the 2007 Proposition 36 Treatment Provider Survey. The results reflect responses from randomly selected Proposition 36 Treatment Providers (n = 87).

Page 35: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Providers’ Perceptions – Would Jail Sanctions for Non-compliance Improve Treatment Outcomes?

19%

1%

80%

0

20

40

60

80

100

No Maybe Yes

Per

cen

t

Notes: Data are from the 2007 Prop 36 Treatment Provider Survey. The results reflect responses from randomly selected Prop 36 Treatment Providers (n = 87).

Page 36: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Behavioral Triage Model

Page 37: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Behavioral Triage Model (BTM)

Treatment decisions based on probationers’ revealed behavior

Allocates treatment resources more efficiently Under diversion programs many

probationers mandated to treatment do not have a diagnosable substance abuse disorder, wasting scarce treatment resources and displacing self-referrals in greater need of care.

Page 38: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Distribution of Positive Drug Tests

0 1 2 3 4 5 60%

10%

20%

30%

40%

50%

60%

51%

28%

12%

5%2% 1% 1%

Number of positive drug tests

Perc

en

tage

Page 39: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Pharmacotherapies for Opiate-Dependent Offenders

Referral to community-based counseling (usually OP)—inexpensive but insufficient.

Methadone & buprenorphine can be effective, but partial agonists are unpopular among CJ administrators.

Oral opioid antagonists are more acceptable, but adherence (as with psychosocial treatments) is low.

Long-acting opioid antagonists Overcome the problem of non-compliance (at least for

monthly segments); Eliminate concerns about potential diversion; Can still be coupled with psychosocial treatment; and A single dose provides protection during the period of

highest risk for relapse and overdose—the first 2-3 weeks following release.

Page 40: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

What is the Evidence for Evidence-Based Offender Programs?

Page 41: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

National Registry of Evidence-based Programs and Practices (NREPP)

Managed and funded by SAMHSA Began in 1997 Purpose: “[T]o assist the public in

identifying approaches to preventing and treating mental and/or substance abuse disorders that have been scientifically tested and that can be readily disseminated to the field.” (NREPP, 2009)

Page 42: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Types of Interventions Included in This Study (N=31)

17

8

6

Substance AbuseMental HealthHybrid

Page 43: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

NREPP Review Criteria Quality of research is reported results

using the following six criteria: Reliability of measures Validity of measures Intervention fidelity Missing data and attrition Potential confounding variables Appropriateness of analysis

Reviewers use a scale of 0.0 to 4.0, with 4.0 being the most favorable.

Page 44: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Distribution of NREPP Quality and Dissemination Readiness Scores (N=31)

<1.0 1.0-1.4

1.5-1.9

2.0-2.4

2.5-2.9

3.0-3.4

3.5-4.0

0

2

4

6

8

10

12

QualityDissemination

Score

Fre

qu

en

cy

Page 45: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Ratings by Program Type (N=31)

Program Type Quality Dissemination

Substance Abuse (n=17)

Mean=2.8 (SD=0.52)Range=1.7-3.8

Mean=2.6 (SD=0.87)Range=0.8-4.0

Mental Health (n=8) Mean=3.0 (SD=0.37)Range=2.2-3.5

Mean=2.7 (SD=0.92)Range=1.3-4.0

Hybrid (n=6) Mean=3.00 (SD=0.49)Range=2.1-3.5

Mean=3.17 (SD=0.82)Range=1.5-3.9

One third of the EBPs had not been replicated.

Page 46: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Developers as Evaluators

Total (N=123)

Hybrid (N=32)

Mental Health (N=27)

Substance Abuse (N=64)

0 10 20 30 40 50 60 70 80 90 100

52

38

56

58

%

Page 47: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Summary: Prevalence

Illicit drug use and dependence is approximately 2-5 times more common among offenders than the general population.

50%-80% of arrestees test positive for at least one illicit drug.

Cocaine use is declining; opiate use is increasing.

Page 48: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Summary: Assessment

Studies of the added value of more complex assessments over that of single-item questions suggest that some offender needs (esp. drug problems) can be assessed using single items with binary responses

70%-90% of those identified as needing AOD, financial, or housing assistance on the COMPAS or LSI-R were also identified with the single-item measures.

Likewise, compared to the ASI drug-use composite measure, the TEA score was as predictive of UA results as the ASI composite score.

Page 49: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Summary: Interventions

Drug court approach can be effective but not a panacea.

BTM may be a useful alternative that helps practitioners focus on those with most severe problems.

Depot medications for opiate dependence address many of the problems associated with offender treatment (e.g., CJS resistance, poor adherence, risk of diversion, high post-release mortality rates).

Page 50: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Summary: Evidence-Based Programs

There is tremendous variation in the quality/dissemination readiness of the CJ-focused NREPP studies.

Lack of evaluator independence undermines confidence in findings.

Inhibits innovation in a field that desperately needs it.

Page 51: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Questions

1. Rates of opiate use among offenders have stabilized over the past 5 years.

a. Trueb. False

Page 52: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Questions

2. Good risk/needs assessment cannot be accomplished without an in-depth client. interviewa. Trueb. False

Page 53: David Farabee Integrated Substance Abuse Programs UCLA Department of Psychiatry & Biobehavioral Sciences

Questions

3. Many offenders with serious drug problems can quit when subjected to frequent, random drug tests coupled with mild sanctions.a. Trueb. False